{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:22:27Z","timestamp":1778070147482,"version":"3.51.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3,13]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Gastric cancer is one of the most common malignant tumors in China. Gastric signet ring cell carcinoma (SRCC) belongs to highly malignant undifferentiated gastric cancer, originating from the epithelial cells of the gastric mucosa. Research has shown that the incidence of gastric cancer is gradually decreasing, but the incidence of gastric SRCC is gradually increasing. We report an extremely rare case of dual primary SRCC involving the gastric cardia and antrum. This case highlights the diagnostic challenges of synchronous SRCC, where a high level of suspicion, comprehensive endoscopic evaluation, and multidisciplinary management are crucial for achieving optimal treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>The 69-year-old female patient presented with poor appetite and significant weight loss, prompting her hospitalization. Following diagnostic evaluations, she was diagnosed with dual primary SRCC involving both the gastric cardia and antrum. Postsurgery, she experienced severe complications, including malnutrition, postoperative infections, and intestinal obstruction, significantly impairing her quality of life. Currently, she remains under regular chemotherapy (Tegio) and trastuzumab-targeted therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was finally diagnosed with double primary SRCC of the cardia and antrum of the stomach through gastroscopy and pathological tissue biopsy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Laparoscopic radical total gastrectomy (October 28, 2024)<\/jats:p>\n                    <jats:p>Adjuvant therapy: Tegio chemotherapy\u2005+\u2005trastuzumab (human epidermal growth factor receptor 2 [HER2] targeted)<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Complications such as malnutrition, postoperative infection, intestinal obstruction, as well as complications related to chemotherapy and targeted therapy, which had a serious impact on the quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Importance of clinical vigilance: Although this patient had no family history of gastric cancer, her nonspecific gastrointestinal symptoms ultimately led to the diagnosis of dual primary SRCC. This highlights the need for high suspicion of malignancy in elderly patients presenting with nonspecific symptoms.<\/jats:p>\n                    <jats:p>Diagnostic value of multidisciplinary collaboration: The integration of endoscopic, pathological, imaging (computed tomography\/magnetic resonance imaging), and immunohistochemical findings enabled accurate diagnosis of this rare case of dual primary gastric malignancy and identification of HER2 expression heterogeneity. The heterogeneity in HER2 expression (1+ vs 3+) demonstrates potential molecular differences between lesions in the same patient, emphasizing the necessity for comprehensive biopsy sampling.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048009","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:01:05Z","timestamp":1773432065000},"page":"e48009","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Synchronous gastric cardia and antrum signet ring cell carcinomas: A rare case report highlighting diagnostic challenges and multidisciplinary management"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0024-2707","authenticated-orcid":false,"given":"Chunmei","family":"Wang","sequence":"first","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Su","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjing","family":"Jie","sequence":"additional","affiliation":[{"name":"Digestive System Department, Red Flag Hospital affiliated to Mudanjiang Medical University, Mudanjiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Teng","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Chen","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Digestive System Department, Tongren People\u2019s Hospital, Tongren, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260506","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/MEG.0000000000000258","article-title":"Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.","volume":"27","author":"Lee","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R2-20260506","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.3748\/wjg.v19.i41.7154","article-title":"Characteristics and prognosis of synchronous multiple early gastric cancer.","volume":"19","author":"Isobe","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R3-20260506","first-page":"3322","article-title":"Synchronous double primary signet ring cell carcinomas of the gastric cardia and antrum: a case report and literature review.","volume":"8","author":"Zhang","year":"2020","journal-title":"World J Clin Cases"},{"key":"R4-20260506","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma.","volume":"513","year":"2014","journal-title":"Nature"},{"key":"R5-20260506","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/a-1811-7025","article-title":"Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) guideline \u2013 update 2022.","volume":"54","author":"Pimentel-Nunes","year":"2022","journal-title":"Endoscopy"},{"key":"R6-20260506","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R7-20260506","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10120-018-0868-0","article-title":"Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.","volume":"22","author":"Mariette","year":"2019","journal-title":"Gastric Cancer"},{"key":"R8-20260506","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10120-018-0860-8","article-title":"Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.","volume":"22","author":"Kao","year":"2019","journal-title":"Gastric Cancer"},{"key":"R9-20260506","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000519650","article-title":"Indications of endoscopic submucosal dissection for undifferentiated early gastric cancer: current status and future perspectives for further expansion.","volume":"103","author":"Shiotsuki","year":"2022","journal-title":"Digestion"},{"key":"R10-20260506","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jviscsurg.2015.09.021","article-title":"Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.","volume":"152","author":"Wang","year":"2015","journal-title":"J Visceral Surg"},{"key":"R11-20260506","first-page":"e236541","article-title":"Synchronous early gastric cancers in a patient with idiopathic Parkinson's disease.","volume":"13","author":"Mannath","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R12-20260506","first-page":"1","article-title":"Japanese gastric cancer treatment guidelines 2021.","volume":"26","year":"2023","journal-title":"Gastric Cancer"},{"key":"R14-20260506","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"R15-20260506","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1007\/s00535-018-1464-0","article-title":"Clinical impact of intratumoral HER2 heterogeneity on trastuzumab efficacy in patients with HER2-positive gastric cancer.","volume":"53","author":"Wakatsuki","year":"2018","journal-title":"J Gastroenterol"},{"key":"R16-20260506","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the college of American pathologists, American society for clinical pathology, and American society of clinical oncology.","volume":"35","author":"Bartley","year":"2017","journal-title":"J Clin Oncol"},{"key":"R17-20260506","first-page":"100475","article-title":"Signet ring cell carcinoma of the gastrointestinal tract: national trends on treatment effects and prognostic outcomes.","volume":"29","author":"Franko","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"R18-20260506","doi-asserted-by":"crossref","first-page":"29336","DOI":"10.18632\/oncotarget.25464","article-title":"Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset.","volume":"9","author":"Tanaka","year":"2018","journal-title":"Oncotarget"},{"key":"R19-20260506","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0960-7404(94)90037-X","article-title":"Prognostic significance of signet ring cell carcinoma of the stomach.","volume":"3","author":"Kim","year":"1994","journal-title":"Surg Oncol"},{"key":"R20-20260506","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.","volume":"52","author":"Van der Post","year":"2015","journal-title":"J Med Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:06:14Z","timestamp":1778069174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048009","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"2025-05-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}